Search

Your search keyword '"Ferlini, Alessandra"' showing total 910 results

Search Constraints

Start Over You searched for: Author "Ferlini, Alessandra" Remove constraint Author: "Ferlini, Alessandra" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
910 results on '"Ferlini, Alessandra"'

Search Results

5. Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience

6. SCN5A mutation is associated with a higher Shanghai Score in patients with type 1 Brugada ECG pattern

7. TeleNEwCARe: An Italian case-control telegenetics study in patients with Hereditary NEuromuscular and CARdiac diseases

8. TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy.

9. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

10. Recommendations for whole genome sequencing in diagnostics for rare diseases

12. SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.

13. SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.

14. Gain and loss of TASK3 channel function and its regulation by novel variation cause KCNK9 imprinting syndrome

15. RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing

16. The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy

19. The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy

20. Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.

21. Patient preferences in genetic newborn screening for rare diseases : study protocol

22. POPDC2 a novel susceptibility gene for conduction disorders

24. Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe

28. Guidance in Social and Ethical Issues Related to Clinical, Diagnostic Care and Novel Therapies for Hereditary Neuromuscular Rare Diseases: “Translating” the Translational

29. Chapter Biomarkers in Rare Genetic Diseases

30. 263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022

32. Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network

33. Twist exome capture allows for lower average sequence coverage in clinical exome sequencing

34. Clinical, genetic, epidemiologic, evolutionary, and functional delineation of TSPEAR-related autosomal recessive ectodermal dysplasia 14

35. A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring

36. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

37. Twist exome capture allows for lower average sequence coverage in clinical exome sequencing

38. A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma : Implications in DMD Diagnosis and Clinical Monitoring

39. Genetic newborn screening and digital technologies : A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe

40. 263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022

42. AFG3L2 Biallelic Mutation: Clinical Heterogeneity in Two Italian Patients

44. Solving unsolved rare neurological diseases-a Solve-RD viewpoint

46. Expanding the clinical spectrum of recessive truncating mutations of KLHL7 to a Bohring-Opitz-like phenotype

47. A current approach to heart failure in Duchenne muscular dystrophy

48. causes muscular dystrophy and arrhythmia by affecting protein trafficking

49. Newborn Screening by Genomic Sequencing: Opportunities and Challenges

Catalog

Books, media, physical & digital resources